An Evaluation of the Efficacy & Safety of AL-46383A Ophthalmic Solution

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Terminated

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of AL-46383A Ophthalmic Solution for the treatment of adenoviral conjunctivitis.

n/a

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT01532336` - Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis	Phase 2
Terminated	`NCT02998554` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo	Phase 3
Terminated	`NCT02998541` - Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo	Phase 3
Completed	`NCT02472223` - Reducing Adenoviral Patient Infected Days	N/A
Withdrawn	`NCT03009799` - Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)	Phase 2
Active, not recruiting	`NCT03856645` - OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis	Phase 2
Completed	`NCT00266734` - Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears	N/A
Completed	`NCT03749317` - Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis	Phase 2